Search Results - "Munir, Sabah S."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Skin Infiltrate Composition as a Telling Measure of Responses to Checkpoint Inhibitors by Kosche, Cory, Jaishankar, Dinesh, Cosgrove, Cormac, Ramesh, Prathyaya, Hong, Suyeon, Li, Lin, Shivde, Rohan S., Bhuva, Deven, White, Bethany E. Perez, Munir, Sabah S., Zhang, Hui, Lu, Kurt Q., Choi, Jennifer N., Le Poole, I. Caroline

    Published in JID innovations (01-09-2023)
    “…Checkpoint inhibitors treat a variety of tumor types with significant benefits. Unfortunately, these therapies come with diverse adverse events. Skin rash is…”
    Get full text
    Journal Article
  2. 2

    First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin by Meghani, Khyati, Cooley, Lauren Folgosa, Choy, Bonnie, Kocherginsky, Masha, Swaminathan, Suchitra, Munir, Sabah S., Svatek, Robert S., Kuzel, Timothy, Meeks, Joshua J.

    Published in European urology (01-12-2022)
    “…We conducted a phase 1 clinical trial of intravesical pembrolizumab and bacillus Calmette-Guérin. The trial found both local and systemic toxicity, and…”
    Get full text
    Journal Article
  3. 3